RenovoRx, Inc. - Common Stock —— 现金流量表 (NASDAQ:RNXT) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -5.92 M-8.81 M-10.26 M-9.13 M-10.97 M -11.3 M 投资活动产生的现金 -15 K-2.03 M2.03 M-12 K-2 000 0 融资活动产生的现金 19.33 M42 K5.01 M15.12 M10.85 M 9.08 M 自由现金流 -5.92 M-8.81 M-10.26 M-9.13 M-10.97 M -11.3 M

新闻

RenovoRx, Inc. (RNXT) Reports Q1 Loss, Tops Revenue Estimates

Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates

Cytokinetics (CYTK) Reports Q1 Loss, Beats Revenue Estimates

Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) Reports Q4 Loss, Misses Revenue Estimates

Oculis Holding AG (OCS) Reports Q4 Loss, Tops Revenue Estimates

Jones Trading 开始对 RenovoRx 股票进行覆盖并给予买入评级

Jones Trading initiates coverage on RenovoRx stock with Buy rating

RenovoRx首席医疗官Agah Ramtin购入价值9975美元股份